HSCs, particularly MAHSCs (IGHG1+, BAG3+, IGFBP3+), play a crucial role in MM pathogenesis, with a negative correlation between their abundance and patient survival (Figures 2G, E, D). Here, IGFBP3 is linked to Miyoshi myopathy.